深圳中山泌尿外科医院


  • 深圳中山泌尿外科医院生殖医学中心于1997年在中国“试管婴儿之父”庄广伦教授的带领下组建而成。本中心由辅助生殖助孕中心、生殖免疫诊疗中心以及生殖与遗传研究所等三个部门组成。

    ART中心提供关于生殖健康的全方位的评估和治疗手段。本中心致力于为来自深圳乃至整个中国的IVF患者提供高质量的服务以及高水平的成功率。本中心拥有一支优秀的高水平的医生团队。目前,本中心平均每年进行5000个IVF周期。临床妊娠率稳定维持在60%。除了临床工作外,本中心同时非常重视科研工作以及与其他中心的学术交流,这使得本中心在这一快速发展的领域里保持在前沿位置。

    生殖免疫诊疗中心于2012年获批为“深圳市围着床期生殖免疫重点实验室”。本部门是生殖中心的重点部门,致力于提高复发性流产以及反复种植失败患者的成功妊娠率。目前,该部门可以提供80余项免疫检查及其对应的有效治疗策略。复发性流产保胎率为85%,反复种植失败的临床妊娠率为59.5%。因此,独具特色的生殖免疫诊疗体系获得了“2015年度深圳市科技进步奖(社会公益类)一等奖”。在此基础上,我中心获批深圳市“医疗卫生三名工程”,与国家973项目首席科学家、复旦大学附属妇产科医院副院长李大金教授作为带头人的生殖免疫诊疗创新团队共同建立了生殖免疫联合研发中心。

    生殖与遗传研究所于2009年由深圳市政府批准成立,其中包括了细胞遗传学、男科以及分子等三个实验室。研究所自主承担了辅助生殖助孕中心患者的全部临床检测,并且为研究人员提供了良好的实验平台。此外,由于高质量的质控工作,研究所在制定广东省生殖中心实验室标准操作程序中发挥了重要作用。

    本中心近年承担省市级课题十余项,发表科研论文100余篇,申请获批专利14项。


    The Fertility Center of Shenzhen Zhongshan Urology Hospital was founded in 1997 by Dr. Zhuang Guang-Lun, who is known as the father of assisted reproductive technology (ART) in China. It is comprised of three departments, including the ART Center, the Department of Reproductive Immunology and the Institute for Reproductive Medicine and Genetics.

    The ART Center offers comprehensive evaluation and fertility treatments of all aspects of reproductive care. We define our center by the quality of care and extraordinary success rate we achieve for IVF in Shenzhen and throughout the China. We have an elite group of doctors who are well recognized for their high success rates and pioneering work in helping infertile couples. The ART Center has been performed approximately 5,000 IVF cycles per year. The clinical pregnancy rate is stabilized around 60%. Besides the clinic work, we highlights the importance of the research work and the academic communications with the great centers which help keeping the ART center at the forefront of this fast-changing field.

    The Department of Reproductive Immunology, which has been awarded the honor of “Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation”, is the key department in our fertility center that dedicates to improve the success rate for the patients with recurrent miscarriage (RM) or repeated implantation failure (RIF). It provides a full range of services including more than eighty immunological tests and several effective therapeutic strategies. At present, ongoing pregnancy rate of RM is 85%, and the clinical pregnancy rate of RIF is 59.5%. Therefore, the unique reproductive immunology diagnostic system got the first prize of Shenzhen Scientific and Technological Progress Award in 2015. Based on these achievements, Prof. Dajin Li, who is chief scientist for National 973 Project, and vice-president of Obstetrics & Gynecology Hospital of Fudan University, lead the innovation team of reproductive immunology diagnosis and treatment to establish Joint Research Center of Reproductive Immunology together with the Department of Reproductive Immunology in Shenzhen Zhongshan Urology Hospital.

    The Institute for Reproductive Medicine and Genetics, which was approved by Shenzhen government in 2009, consists of cytogenetic lab, andrology lab and molecular biology lab. It undertakes almost all of the clinical detection work of the ART patients, and serves as a platform for researchers. In addition, due to the high quality control (QC) work, the institute plays a leading role in developing the Standard Operating Procedures (SOP) of general laboratory work for fertility centers in Guangdong Province.

    During recent years, we have undertook more than 10 provincial and municipal key projects, published more than 100 papers and obtained 14 patents on both clinical practice and research areas of human fertility and sterility.


        © 2016 深圳中山泌尿外科医院生殖免疫诊疗中心 | 版权所有  | 粤ICP备09202628号  

    © 2016 Clinical Center for Reproductive Immunology, Shenzhen Zhongshan Urology Hospital | All rights reserved